Clinical Trials Sponsored by Graceway Pharmaceuticals, LLC

Total 622 results

Graceway Pharmaceuticals, LLC

Completed

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Vaginosis, Bacterial | Vaginal Infection

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
Graceway Pharmaceuticals, LLC

Completed

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Warts
Graceway Pharmaceuticals, LLC

Completed

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Actinic Keratosis

United States, Canada
Graceway Pharmaceuticals, LLC

Completed

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

Actinic Keratoses
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

Basal Cell Carcinoma

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling

Skin Wrinkling

United States
Graceway Pharmaceuticals, LLC

Completed

Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
St. Justine's Hospital
Graceway Pharmaceuticals, LLC

Completed

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

Hemangioma, Capillary

Canada
University of Miami
Graceway Pharmaceuticals, LLC

Completed

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Healthy

United States
Frankel, Amylynne, M.D.
Graceway Pharmaceuticals, LLC

Unknown

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Actinic Keratosis

United States
Tennessee Clinical Research Center
Graceway Pharmaceuticals, LLC

Terminated

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Actinic Keratosis

United States
Henry Vasconez
Graceway Pharmaceuticals, LLC

Terminated

The Effects of Aldara as an Adjunct to Laser Treatment

Port Wine Stains

United States
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS (OS440-3005)

Multiple Sclerosis | Spasticity, Muscle

United States
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Withdrawn

To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS

Multiple Sclerosis | Sperm

United States
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

Multiple Sclerosis | Spasticity

United States, Russian Federation, Ukraine
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS (OS440-3004)

Multiple Sclerosis | Spasticity, Muscle

Serbia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Moldova, Republic of, Poland
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United States, Russian Federation, Ukraine
Amneal Pharmaceuticals, LLC
Novum Pharmaceutical Research Services

Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Amneal Pharmaceuticals, LLC
Symbio, LLC

Completed

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Uncomplicated Urinary Tract Infections

United States
Saptalis Pharmaceuticals LLC
bioRASI, LLC

Completed

A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

Scabies

United States
Hikma Pharmaceuticals LLC

Not yet recruiting

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia
Kind Pharmaceuticals LLC

Not yet recruiting

A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes
Deciphera Pharmaceuticals LLC

Not yet recruiting

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

Melanoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Pancreatic Ductal Adenocarcinoma | BRAF Gene Mutation | RAS Mutation | NF1 Mutation | RAF Mutation | CRAF Gene Mutation

United States
Deciphera Pharmaceuticals LLC

Recruiting

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)

GIST

United States, Korea, Republic of, Spain, Taiwan, Australia, Canada, United Kingdom, Italy, Netherlands, Brazil, Chile, Poland
Deciphera Pharmaceuticals LLC

Recruiting

A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors

Melanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Pancreatic Ductal Adenocarcinoma

United States
Deciphera Pharmaceuticals LLC

Active, not recruiting

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST

GIST - Gastrointestinal Stromal Tumor

United States
MSD Pharmaceuticals LLC

Completed

ART First-line Treatment Durability in Russia

HIV-1-infection

Russian Federation
Deciphera Pharmaceuticals LLC

Active, not recruiting

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (INTRIGUE)

Gastrointestinal Stromal Tumors

United States, Korea, Republic of, Norway, Spain, Netherlands, Australia, Taiwan, France, United Kingdom, Belgium, Singapore, Canada, Italy, Poland, Sweden, Hungary, Germany, Israel, Czechia, Argentina, Chile, Switzerland
Deciphera Pharmaceuticals LLC

Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Gastrointestinal Stromal Tumors | Advanced Cancers | Advanced Systemic Mastocytosis

United States, Canada, Germany, Italy, Netherlands, United Kingdom
Arjil Pharmaceuticals LLC

Terminated

A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Dermatitis, Atopic

Taiwan
Asklepion Pharmaceuticals, LLC

Completed

L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects

Acute Lung Injury

United States, Israel, Germany, Austria
Asklepion Pharmaceuticals, LLC

Completed

Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19

Acute Hypoxemic Respiratory Failure

United States
Yamo Pharmaceuticals LLC

Completed

Safety of L1-79 in Autism

Autism

United States
Asklepion Pharmaceuticals, LLC

Completed

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol

Atrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal Defect

United States
Cali Pharmaceuticals LLC

Completed

A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

Inguinal Herniorrhaphy

United States
Salarius Pharmaceuticals, LLC

Completed

Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States

Clinical Trials Sponsored by Graceway Pharmaceuticals, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations